BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2432822)

  • 1. Drug-induced changes in the efflux of dopamine and serotonin metabolites from the brains of freely moving rats.
    Moore KE
    Ann N Y Acad Sci; 1986; 473():303-20. PubMed ID: 2432822
    [No Abstract]   [Full Text] [Related]  

  • 2. Measurement of metabolites of dopamine and 5-hydroxytryptamine in cerebroventricular perfusates of unanesthetized, freely-moving rats: selective effects of drugs.
    Nielsen JA; Moore KE
    Pharmacol Biochem Behav; 1982 Jan; 16(1):131-7. PubMed ID: 6173884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerance develops to the haloperidol-induced increase in the efflux of dopamine metabolites from the brains of unanesthetized, freely-moving rats.
    Nielsen JA; Duda NJ; Moore KE
    Life Sci; 1982 Oct; 31(14):1495-1500. PubMed ID: 6183554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional distribution to recovery of 5-HT levels after administration of "atrophins" MDMA and D,L-fenfluramine. Stereospecificity and comparison with 5,7-dihydroxytryptamine.
    Lehmann J; DeSouza EB; Culp S; Zaczek R
    Ann N Y Acad Sci; 1992 May; 648():291-5. PubMed ID: 1379013
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of chloral hydrate, gamma-butyrolactone, and equithesin on the efflux of dopamine and 5-hydroxytryptamine metabolites into cerebroventricular perfusates of rats.
    Nielsen JA; Moore KE
    J Neurochem; 1982 Jul; 39(1):235-8. PubMed ID: 6177832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acrylamide-induced changes in the monoamines and their acid metabolites in different regions of the rat brain.
    Ali SF
    Toxicol Lett; 1983 Jun; 17(1-2):101-5. PubMed ID: 6194574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phasic alterations in dopamine metabolites following continuous administration of amphetamine.
    Ellison G
    Brain Res; 1983 Jun; 268(2):387-9. PubMed ID: 6191836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 6-Hydroxydopamine and 5,7-dihydroxytryptamine selectively reduce dopamine and 5-hydroxytryptamine metabolites in cerebroventricular perfusates of rats.
    Nielsen JA; Moore KE
    Pharmacol Biochem Behav; 1983 Nov; 19(5):905-7. PubMed ID: 6417682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 2-guanidinoethanol on levels of monoamines and their metabolites in the rat brain.
    Yokoi I; Itoh T; Yufu K; Akiyama K; Satoh M; Murakami S; Kabuto H; Mori A
    Neurochem Res; 1991 Oct; 16(10):1155-9. PubMed ID: 1724554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin and dopamine metabolites in brain regions and cerebrospinal fluid of a primate species: effects of ketamine and fluphenazine.
    Bacopoulos NG; Redmond DE; Roth RH
    J Neurochem; 1979 Apr; 32(4):1215-8. PubMed ID: 107277
    [No Abstract]   [Full Text] [Related]  

  • 11. Alterations in brain dopamine and serotonin metabolism during the development of tolerance to human beta-endorphin in rats.
    Van Loon GR; De Souza EB; Kim C
    Can J Physiol Pharmacol; 1978 Dec; 56(6):1067-71. PubMed ID: 743624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic treatment with haloperidol or fluphenazine decanoate: regional effects on dopamine and serotonin metabolism in primate brain.
    Bacopoulos NG; Bustos G; Redmond DE; Roth RH
    J Pharmacol Exp Ther; 1982 Apr; 221(1):22-8. PubMed ID: 6174729
    [No Abstract]   [Full Text] [Related]  

  • 13. MK-801 protects against amphetamine-induced striatal dopamine depletion in iprindole-treated rats, but not against brain serotonin depletion after p-chloroamphetamine administration.
    Henderson MG; Hemrick-Luecke S; Fuller RW
    Ann N Y Acad Sci; 1992 May; 648():286-8. PubMed ID: 1379012
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of subchronic exposure to styrene on the extracellular and tissue levels of dopamine, serotonin and their metabolites in rat brain.
    Gagnaire F; Chalansonnet M; Carabin N; Micillino JC
    Arch Toxicol; 2006 Oct; 80(10):703-12. PubMed ID: 16518643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of 5-HT3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens.
    Chen JP; van Praag HM; Gardner EL
    Brain Res; 1991 Mar; 543(2):354-7. PubMed ID: 1711914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of neurochemical evidence for neurotoxic effects of repeated cocaine administration in rats on brain monoamine neurons.
    Yeh SY; De Souza EB
    Drug Alcohol Depend; 1991 Jan; 27(1):51-61. PubMed ID: 1709403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electroconvulsive shock produces large increases in interstitial concentrations of dopamine in the rat striatum: an in vivo microdialysis study.
    Nomikos GG; Zis AP; Damsma G; Fibiger HC
    Neuropsychopharmacology; 1991 Jan; 4(1):65-9. PubMed ID: 1706182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of low-dose 4-fluorotranylcypromine on rat brain monoamine oxidase and neurotransmitter amines.
    Sherry RL; Baker GB; Coutts RT
    Biol Psychiatry; 1990 Sep; 28(6):539-43. PubMed ID: 1699613
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of cyanide on the extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, 5-hydroxyindoleacetic acid and inositol phospholipid breakdown in the brain.
    Cassel GE; Koch M; Tiger G
    Neurotoxicology; 1995; 16(1):73-82. PubMed ID: 7541518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The extracellular content of dopamine, its metabolites and 5-hydroxyindoleacetic acid in the amygdala of free-moving rats during an act of interspecific aggression].
    Gaĭnetdinov RR; Gromov AI; Kudrin VS
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1991; 41(3):584-6. PubMed ID: 1718096
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.